Purchase by Nissenson Allen of 2037 shares of Elicio Therapeutics
| ELTX Stock | 4.88 0.20 3.94% |
Slightly above 61% of Elicio Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Elicio Therapeutics stock suggests that many investors are alarmed at this time. Elicio Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Elicio Therapeutics' earnings reports, geopolitical events, and overall market trends.
Elicio |
Filed transaction by Elicio Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Elicio Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Elicio Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Elicio Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Elicio Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Elicio Therapeutics Fundamental Analysis
We analyze Elicio Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elicio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elicio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Elicio Therapeutics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Elicio Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elicio Therapeutics stock to make a market-neutral strategy. Peer analysis of Elicio Therapeutics could also be used in its relative valuation, which is a method of valuing Elicio Therapeutics by comparing valuation metrics with similar companies.
Peers
Elicio Therapeutics Related Equities
| ORIC | Oric Pharmaceuticals | 6.76 | ||||
| GLUE | Monte Rosa | 6.45 | ||||
| LYRA | Lyra Therapeutics | 5.88 | ||||
| INBX | Inhibrx | 5.19 | ||||
| SNSE | Sensei Biotherapeutics | 4.65 | ||||
| DSGN | Design Therapeutics | 4.34 | ||||
| ERAS | Erasca | 3.67 | ||||
| NXTC | NextCure | 2.11 | ||||
| NUVB | Nuvation Bio | 0.37 | ||||
| EPIX | ESSA Pharma | 0.62 |
Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.